NCT02049606View on ClinicalTrials.gov

To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

February 24, 2014

Primary Completion Date

May 11, 2015

Study Completion Date

May 30, 2016

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

LAYLA tablet

1 Tablet twice a day

DRUG

CENATONE tablet

2 Tablets once a day

Trial Locations (6)

Unknown

Asan Medical Center, Seoul

Chung-Ang University Hospital, Seoul

Inje University Seoul Paik Hospital, Seoul

Seoul National University Hospital, Seoul

SMG-SNU Boramae Medical Center, Seoul

The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul

All Listed Sponsors
lead

PMG Pharm Co., Ltd

INDUSTRY

NCT02049606 - To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee | Biotech Hunter | Biotech Hunter